*Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom;
†Division of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, United Kingdom; and
‡Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Reprint requests: Tsveta Ivanova, MD, PhD, Manchester Royal Eye Hospital, Manchester University NHS Trust, Oxford Road, Manchester, M13 9WL; e-mail: [email protected]
None of the authors has any financial/conflicting interests to disclose.
All authors have made substantial contributions to the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be submitted.
As this was a retrospective anonymized study, as per our local protocol from our Clinical Effectiveness Department, and as per national guidelines from the National Code of Clinical Research, and the Health Research Authority (HRA), this study has ethical approval exemption and no patient consent was required for participation. All procedures were completed before the design of this study. Patients were diagnosed and treated according to local guidelines and agreements, and written consent from patients was acquired before all procedures as clinically indicated. This study does not report on the use of new or experimental protocols.
Patients and the public were not involved in this study because of its retrospective design.
